Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 23 10:20AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-28.65 Insider Own- Shs Outstand0.15M Perf Week-25.55%
Market Cap0.45M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-11.61%
Income-8.44M PEG- EPS next Q- Inst Own12.56% Short Float- Perf Quarter14.57%
Sales5.64M P/S0.08 EPS this Y- Inst Trans-58.10% Short Ratio0.38 Perf Half Y-35.81%
Book/sh0.85 P/B2.77 EPS next Y- ROA-102.77% Short Interest0.01M Perf Year-57.48%
Cash/sh13.37 P/C0.18 EPS next 5Y- ROE-156.80% 52W Range1.80 - 5.90 Perf YTD-1.66%
Dividend Est.- P/FCF- EPS past 5Y13.28% ROI-252.56% 52W High-60.00% Beta1.21
Dividend TTM- Quick Ratio1.55 Sales past 5Y1301.35% Gross Margin-37.54% 52W Low31.12% ATR (14)0.24
Dividend Ex-Date- Current Ratio1.67 EPS Y/Y TTM26.17% Oper. Margin-114.53% RSI (14)38.01 Volatility15.89% 9.28%
Employees60 Debt/Eq0.08 Sales Y/Y TTM-8.84% Profit Margin-149.49% Recom1.00 Target Price6.87
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q95.41% Payout- Rel Volume0.89 Prev Close2.37
Sales Surprise- EPS Surprise- Sales Q/Q-7.17% EarningsFeb 23 AMC Avg Volume30.22K Price2.36
SMA20-16.93% SMA50-7.04% SMA200-26.10% Trades Volume4,604 Change-0.42%
Apr-22-24 03:00PM
Apr-18-24 12:17PM
Apr-17-24 08:00AM
Apr-16-24 08:00AM
Apr-12-24 09:00AM
08:00AM Loading…
Apr-11-24 08:00AM
Apr-08-24 08:00AM
Apr-02-24 08:05AM
Mar-26-24 08:00AM
Mar-25-24 08:00AM
Feb-28-24 08:00AM
Jan-31-24 08:00AM
Jan-05-24 08:00AM
Dec-29-23 09:00AM
Dec-14-23 08:00AM
08:00AM Loading…
Dec-12-23 08:00AM
Oct-30-23 08:00AM
Oct-18-23 08:30AM
Oct-06-23 09:00AM
Sep-27-23 03:40PM
Sep-15-23 09:00AM
Sep-12-23 08:00AM
Sep-11-23 08:30AM
Sep-01-23 10:00AM
Aug-30-23 08:45AM
Aug-09-23 08:00AM
Jul-28-23 08:00AM
Jul-21-23 08:00AM
03:00PM Loading…
May-26-23 03:00PM
May-23-23 08:00AM
Apr-28-23 08:00AM
Apr-27-23 08:00AM
Apr-19-23 08:00AM
Mar-27-23 08:00AM
Mar-13-23 08:00AM
Feb-09-23 08:00AM
Feb-07-23 10:00AM
Feb-06-23 08:00AM
Feb-03-23 08:35AM
Feb-01-23 02:22PM
Jan-30-23 08:00AM
Jan-24-23 08:00AM
Jan-11-23 08:00AM
Dec-06-22 08:00AM
Nov-10-22 08:00AM
Nov-09-22 08:00AM
Oct-25-22 09:14AM
Oct-13-22 08:00AM
Sep-29-22 08:00AM
Sep-02-22 08:00AM
Aug-30-22 08:00AM
Jul-28-22 08:00AM
Jul-18-22 08:00AM
Jul-14-22 08:00AM
Jul-05-22 08:00AM
Jul-01-22 08:00AM
Jun-16-22 08:00AM
May-16-22 09:00AM
Apr-08-22 08:00AM
Feb-23-22 08:00AM
Feb-22-22 08:00AM
Jan-19-22 09:00AM
Dec-21-21 08:00AM
Dec-10-21 07:30AM
Dec-09-21 07:30AM
Oct-25-21 08:30AM
Oct-04-21 08:00AM
Sep-30-21 09:00AM
Sep-28-21 08:04AM
Sep-09-21 09:00AM
Aug-31-21 09:00AM
Aug-16-21 08:00AM
Jul-26-21 08:25AM
Jul-19-21 09:27AM
Jul-09-21 08:00AM
Jun-11-21 08:00AM
Jun-01-21 08:00AM
May-13-21 09:01AM
Apr-26-21 08:00AM
Apr-12-21 09:37AM
Apr-09-21 11:15AM
Mar-04-21 07:00AM
Feb-26-21 09:20AM
Jan-25-21 04:00PM
Jan-21-21 11:30AM
Dec-02-20 09:00AM
Dec-01-20 09:50AM
Nov-23-20 04:30PM
Nov-17-20 08:30AM
Oct-01-20 08:00AM
Sep-15-20 08:00AM
Sep-11-20 08:33AM
Genetic Technologies Ltd. operates as a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. It operates through EasyDNA, AffinityDNA and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment focuses on AffinityDNA branded test sales and expenses.The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.